International Journal of Bipolar Disorders

Papers
(The H4-Index of International Journal of Bipolar Disorders is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Psychological symptoms during and after Austrian first lockdown in individuals with bipolar disorder? A follow-up control-group investigation30
Lithium and its effects: does dose matter?29
Internet of things issues related to psychiatry25
Key questions on the long term renal effects of lithium: a review of pertinent data22
The association between variability, intensity, and persistence of suicidal ideation and prospective suicidal behavior in the systematic treatment enhancement program for bipolar disorder (STEP-BD) st18
Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal 17
Lithium in the time of COVID: forever vigilant12
Paediatric bipolar disorder: an age-old problem12
A systematic review of the biomarkers associated with cognition and mood state in bipolar disorder12
The big five model in bipolar disorder: a latent profile analysis and its impact on longterm illness severity11
Evaluating the quality, safety, and functionality of commonly used smartphone apps for bipolar disorder mood and sleep self-management11
Mitochondrial genetic variants associated with bipolar disorder and Schizophrenia in a Japanese population11
Dynamics of affect modulation in neurodevelopmental disorders (DynAMoND) – study design of a prospective cohort study11
Association between childhood trauma, cognition, and psychosocial function in a large sample of partially or fully remitted patients with bipolar disorder and healthy participants11
Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol11
0.031440019607544